In the 2026 ADA Scientific Sessions, results from the Phase-3 TRANSCEND-T2D-1 study involving retatrutide, a triple agonist of GLP-1, GIP, and glucagon receptors, showed up to a 2% decrease in A1C and a 16.8% decrease in body weight over 40 weeks in patients with type 2 diabetes
Or maybe semaglutide could serve as a therapeutic but not enough of the drug slipped into patients brains to make a difference
After different groups of HUVECs are treated accordingly, they are seeded into 24-well plates pre-coated with 150 L/well growth factor-reduced Matrigel (Corning, catalog number 354234) and incubated at 37 C in a cell culture incubator for 12 h
Its sequence includes nonstandard or modified residues and is commonly written as Aib-His-D-2-Nal-D-Phe-Lys-NH
Genetic and biochemical findings in Chinese children with Leigh syndrome
Ongoing research means it may be years before these medications are sufficiently understood or recognized as appropriate for addiction treatment